Augmedix Statistics
Total Valuation
FRA:MCHA has a market cap or net worth of EUR 21.67 billion. The enterprise value is 26.09 billion.
Market Cap | 21.67B |
Enterprise Value | 26.09B |
Important Dates
The last earnings date was Thursday, July 24, 2025.
Earnings Date | Jul 24, 2025 |
Ex-Dividend Date | May 21, 2025 |
Share Statistics
Current Share Class | 705.75M |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.90% |
Shares Change (QoQ) | +0.18% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 656.14M |
Valuation Ratios
The trailing PE ratio is 13.91 and the forward PE ratio is 9.01.
PE Ratio | 13.91 |
Forward PE | 9.01 |
PS Ratio | 0.81 |
PB Ratio | 1.22 |
P/TBV Ratio | 1.66 |
P/FCF Ratio | 14.37 |
P/OCF Ratio | 6.41 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.33, with an EV/FCF ratio of 17.30.
EV / Earnings | 16.75 |
EV / Sales | 0.98 |
EV / EBITDA | 5.33 |
EV / EBIT | 9.32 |
EV / FCF | 17.30 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.42.
Current Ratio | 1.80 |
Quick Ratio | 0.87 |
Debt / Equity | 0.42 |
Debt / EBITDA | 1.55 |
Debt / FCF | 4.99 |
Interest Coverage | 11.34 |
Financial Efficiency
Return on equity (ROE) is 8.81% and return on invested capital (ROIC) is 6.77%.
Return on Equity (ROE) | 8.81% |
Return on Assets (ROA) | 4.79% |
Return on Invested Capital (ROIC) | 6.77% |
Return on Capital Employed (ROCE) | 10.07% |
Revenue Per Employee | 220,992 |
Profits Per Employee | 12,876 |
Employee Count | 121,610 |
Asset Turnover | 0.74 |
Inventory Turnover | 3.38 |
Taxes
In the past 12 months, FRA:MCHA has paid 540.00 million in taxes.
Income Tax | 540.00M |
Effective Tax Rate | 25.63% |
Stock Price Statistics
The stock price has decreased by -9.35% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -9.35% |
50-Day Moving Average | 31.97 |
200-Day Moving Average | 32.31 |
Relative Strength Index (RSI) | 38.06 |
Average Volume (20 Days) | 200 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:MCHA had revenue of EUR 26.74 billion and earned 1.56 billion in profits. Earnings per share was 2.19.
Revenue | 26.74B |
Gross Profit | 7.38B |
Operating Income | 2.76B |
Pretax Income | 2.11B |
Net Income | 1.56B |
EBITDA | 4.60B |
EBIT | 2.76B |
Earnings Per Share (EPS) | 2.19 |
Balance Sheet
The company has 3.12 billion in cash and 7.52 billion in debt, giving a net cash position of -4.40 billion.
Cash & Cash Equivalents | 3.12B |
Total Debt | 7.52B |
Net Cash | -4.40B |
Net Cash Per Share | n/a |
Equity (Book Value) | 17.74B |
Book Value Per Share | 25.11 |
Working Capital | 6.58B |
Cash Flow
In the last 12 months, operating cash flow was 3.38 billion and capital expenditures -1.87 billion, giving a free cash flow of 1.51 billion.
Operating Cash Flow | 3.38B |
Capital Expenditures | -1.87B |
Free Cash Flow | 1.51B |
FCF Per Share | n/a |
Margins
Gross margin is 27.60%, with operating and profit margins of 10.30% and 5.84%.
Gross Margin | 27.60% |
Operating Margin | 10.30% |
Pretax Margin | 7.88% |
Profit Margin | 5.84% |
EBITDA Margin | 17.19% |
EBIT Margin | 10.30% |
FCF Margin | 5.64% |
Dividends & Yields
This stock pays an annual dividend of 1.38, which amounts to a dividend yield of 4.44%.
Dividend Per Share | 1.38 |
Dividend Yield | 4.44% |
Dividend Growth (YoY) | 2.22% |
Years of Dividend Growth | 4 |
Payout Ratio | 62.40% |
Buyback Yield | 0.90% |
Shareholder Yield | 5.34% |
Earnings Yield | 7.19% |
FCF Yield | 6.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on June 16, 2022. It was a forward split with a ratio of 4.
Last Split Date | Jun 16, 2022 |
Split Type | Forward |
Split Ratio | 4 |
Scores
FRA:MCHA has an Altman Z-Score of 2.65 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.65 |
Piotroski F-Score | 5 |